Association of interleukin-10 polymorphisms with schizophrenia: A meta-analysis

PLoS ONE

Volumn 9, Issue 3, 2014, Pages

  Gao, Lei ^a,b   Li, Zhao ^a,b   Chang, Suhua ^a   Wang, Jing ^a  

^a INSTITUTE OF PSYCHOLOGY   (China)

^b INSTITUTE OF GEOLOGY AND GEOPHYSICS   (China)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 10;

ARTICLE; ASIAN; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC SUSCEPTIBILITY; HAPLOTYPE; HUMAN; MOLECULAR PATHOLOGY; RISK FACTOR; SCHIZOPHRENIA; SINGLE NUCLEOTIDE POLYMORPHISM; SYSTEMATIC REVIEW; GENETICS; META ANALYSIS;

HAPLOTYPES; HUMANS; INTERLEUKIN-10; POLYMORPHISM, SINGLE NUCLEOTIDE; SCHIZOPHRENIA;

EID: 84897468952     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0090407     Document Type: Article

References (42)

1. van Os J, Kapur S (2009) Schizophrenia. Lancet 374: 635-645.
2. Karayiorgou M, Gogos JA (1997) A turning point in schizophrenia genetics. Neuron 19: 967-979. (Pubitemid 27512359)
3. Fatemi SH, Folsom TD (2009) The neurodevelopmental hypothesis of schizophrenia, revisited. Schizophr Bull 35: 528-548.
4. Howes OD, Kapur S (2009) The dopamine hypothesis of schizophrenia: version III-the final common pathway. Schizophr Bull 35: 549-562.
5. Moghaddam B, Javitt D (2012) From revolution to evolution: the glutamate hypothesis of schizophrenia and its implication for treatment. Neuropsychopharmacology 37: 4-15.
6. Muller N, Riedel M, Ackenheil M, Schwarz MJ (1999) The role of immune function in schizophrenia: an overview. Eur Arch Psychiatry Clin Neurosci 249 Suppl 4: 62-68.
7. Meyer U, Feldon J, Yee BK (2009) A review of the fetal brain cytokine imbalance hypothesis of schizophrenia. Schizophr Bull 35: 959-972.
8. Haroon E, Raison CL, Miller AH (2012) Psychoneuroimmunology meets neuropsychopharmacology: translational implications of the impact of inflammation on behavior. Neuropsychopharmacology 37: 137-162.
9. Luo XJ, Li M, Huang L, Nho K, Deng M, et al. (2012) The interleukin 3 gene (IL3) contributes to human brain volume variation by regulating proliferation and survival of neural progenitors. PLoS One 7: e50375.
10. Potvin S, Stip E, Sepehry AA, Gendron A, Bah R, et al. (2008) Inflammatory cytokine alterations in schizophrenia: a systematic quantitative review. Biol Psychiatry 63: 801-808. (Pubitemid 351410515)
11. Watanabe Y, Someya T, Nawa H (2010) Cytokine hypothesis of schizophrenia pathogenesis: evidence from human studies and animal models. Psychiatry Clin Neurosci 64: 217-230.
12. Nawa H, Takei N (2006) Recent progress in animal modeling of immune inflammatory processes in schizophrenia: implication of specific cytokines. Neurosci Res 56: 2-13. (Pubitemid 44376487)
13. Tourjman V, Kouassi E, Koue ME, Rocchetti M, Fortin-Fournier S, et al. (2013) Antipsychotics' effects on blood levels of cytokines in schizophrenia: A meta-analysis. Schizophr Res.
14. Sommer IE, van Westrhenen R, Begemann MJ, de Witte LD, Leucht S, et al. (2013) Efficacy of Anti-inflammatory Agents to Improve Symptoms in Patients With Schizophrenia: An Update. Schizophr Bull.
15. Fiorentino DF, Zlotnik A, Vieira P, Mosmann TR, Howard M, et al. (1991) IL- 10 acts on the antigen-presenting cell to inhibit cytokine production by Th1 cells. J Immunol 146: 3444-3451.
16. Meyer U, Murray PJ, Urwyler A, Yee BK, Schedlowski M, et al. (2008) Adult behavioral and pharmacological dysfunctions following disruption of the fetal brain balance between pro-inflammatory and IL-10-mediated anti-inflammatory signaling. Mol Psychiatry 13: 208-221.
17. Miller BJ, Buckley P, Seabolt W, Mellor A, Kirkpatrick B (2011) Meta-analysis of cytokine alterations in schizophrenia: clinical status and antipsychotic effects. Biol Psychiatry 70: 663-671.
18. Dimitrov DH, Lee S, Yantis J, Valdez C, Paredes RM, et al. (2013) Differential correlations between inflammatory cytokines and psychopathology in veterans with schizophrenia: Potential role for IL-17 pathway. Schizophr Res 151: 29-35.
19. Sugino H, Futamura T, Mitsumoto Y, Maeda K, Marunaka Y (2009) Atypical antipsychotics suppress production of proinflammatory cytokines and upregulate interleukin-10 in lipopolysaccharide-treated mice. Prog Neuropsychopharmacol Biol Psychiatry 33: 303-307.
20. Bocchio Chiavetto L, Boin F, Zanardini R, Popoli M, Michelato A, et al. (2002) Association between promoter polymorphic haplotypes of interleukin-10 gene and schizophrenia. Biol Psychiatry 51: 480-484. (Pubitemid 34260969)
21. Yu L, Yang MS, Zhao J, Shi YY, Zhao XZ, et al. (2004) An association between polymorphisms of the interleukin-10 gene promoter and schizophrenia in the Chinese population. Schizophr Res 71: 179-183. (Pubitemid 39209487)
22. Shirts BH, Bamne M, Kim JJ, Talkowski M, Wood J, et al. (2006) A comprehensive genetic association and functional study of TNF in schizophrenia risk. Schizophr Res 83: 7-13.
23. Peng HY, Ku YC, Shu BC, Lung FW (2008) Association between Interleukin-10 Gene Promoter Haplotype and Schizophrenia in a Han-Chinese Study. Int J Biomed Sci 4: 185-191.
24. Ozbey U, Tug E, Namli M (2009) Interleukin-10 gene promoter polymorphism in patients with schizophrenia in a region of East Turkey. World J Biol Psychiatry 10: 461-468.
25. Almoguera B, Riveiro-Alvarez R, Lopez-Castroman J, Dorado P, Lopez-Rodriguez R, et al. (2011) ATA homozigosity in the IL-10 gene promoter is a risk factor for schizophrenia in Spanish females: a case control study. BMC Med Genet 12: 81.
26. Jun TY, Pae CU, Kim KS, Han H, Serretti A (2003) Interleukin-10 gene promoter polymorphism is not associated with schizophrenia in the Korean population. Psychiatry Clin Neurosci 57: 153-159. (Pubitemid 36505271)
27. Jun TY, Pae CU, Chae JH, Bahk WM, Kim KS, et al. (2002) Report on IL-10 gene polymorphism at position -819 for major depression and schizophrenia in Korean population. Psychiatry Clin Neurosci 56: 177-180.
28. Paul-Samojedny M, Kowalczyk M, Suchanek R, Owczarek A, Fila-Danilow A, et al. (2010) Functional polymorphism in the interleukin-6 and interleukin-10 genes in patients with paranoid schizophrenia-a case-control study. J Mol Neurosci 42: 112-119.
29. Lung FW, Yang MC, Shu BC (2011) The interleukin 10 promoter haplotype ACA and the long-form variant of the DRD4 uVNTR polymorphism are associated with vulnerability to schizophrenia. Psychiatry Res 188: 294-296.
30. Schizophrenia Psychiatric Genome-Wide Association Study C (2011) Genome-wide association study identifies five new schizophrenia loci. Nat Genet 43: 969-976.
31. Moher D, Liberati A, Tetzlaff J, Altman DG, Group P (2009) Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med 6: e1000097.
32. Attia J, Thakkinstian A, D'Este C (2003) Meta-analyses of molecular association studies: methodologic lessons for genetic epidemiology. J Clin Epidemiol 56:297-303. (Pubitemid 36593307)
33. Thakkinstian A, McElduff P, D'Este C, Duffy D, Attia J (2005) A method for meta-analysis of molecular association studies. Stat Med 24: 1291-1306. (Pubitemid 40585169)
34. Bland JM, Altman DG (1995) Multiple significance tests: the Bonferroni method. BMJ 310: 170.
35. Verhagen M, van der Meij A, van Deurzen PA, Janzing JG, Arias-Vasquez A, et al. (2010) Meta-analysis of the BDNF Val66Met polymorphism in major depressive disorder: effects of gender and ethnicity. Mol Psychiatry 15: 260-271.
36. Zintzaras E (2010) Impact of Hardy-Weinberg equilibrium deviation on allele-based risk effect of genetic association studies and meta-analysis. Eur J Epidemiol 25: 553-560.
37. Higgins JP, Thompson SG (2002) Quantifying heterogeneity in a meta-analysis. Stat Med 21: 1539-1558. (Pubitemid 34746062)
38. Egger M, Davey Smith G, Schneider M, Minder C (1997) Bias in meta-analysis detected by a simple, graphical test. BMJ 315: 629-634. (Pubitemid 27387172)
39. Rood MJ, Keijsers V, van der Linden MW, Tong TQ, Borggreve SE, et al. (1999) Neuropsychiatric systemic lupus erythematosus is associated with imbalance in interleukin 10 promoter haplotypes. Ann Rheum Dis 58: 85-89. (Pubitemid 29116307)
40. Crawley E, Kay R, Sillibourne J, Patel P, Hutchinson I, et al. (1999) Polymorphic haplotypes of the interleukin-10 59 flanking region determine variable interleukin-10 transcription and are associated with particular phenotypes of juvenile rheumatoid arthritis. Arthritis Rheum 42: 1101-1108. (Pubitemid 29268946)
41. Edwards-Smith CJ, Jonsson JR, Purdie DM, Bansal A, Shorthouse C, et al. (1999) Interleukin-10 promoter polymorphism predicts initial response of chronic hepatitis C to interferon alfa. Hepatology 30: 526-530. (Pubitemid 29357520)
42. Ghasemi H, Ghazanfari T, Yaraee R, Owlia P, Hassan ZM, et al. (2012) Roles of IL-10 in ocular inflammations: a review. Ocul Immunol Inflamm 20: 406-418.